3
|
Schmidt N, Strohmaier T, Witt K. A modified version of the interlocking finger test as a bedside screening test for visuospatial deficits and dementia in Parkinson's disease. Brain Behav 2022; 12:e2516. [PMID: 35257517 PMCID: PMC9015001 DOI: 10.1002/brb3.2516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 12/11/2021] [Accepted: 01/22/2022] [Indexed: 11/07/2022] Open
Abstract
INTRODUCTION Objective of this study was to examine if the Interlocking Finger Test (ILFT) is a suitable bedside screening test for visuospatial functions and/or dementia in Parkinson's disease (PD) patients aiming to facilitate the diagnosis of a dementia syndrome associated with posterior cortical and temporal lobe dysfunction according to the dual syndrome hypothesis (frontostriatal vs. posterior cortical cognitive impairment). METHODS Forty-seven PD patients were assessed with the ILFT and an extensive cognitive test battery. The ILFT was carried out in the original version as well as in three modified versions of the test including a fifth figure and/or a more complex rating system, leading to four different ILFT scores (named after the maximum achievable scoring result: ILFT 4, ILFT 5, ILFT 12, and ILFT 15). We conducted a correlation analysis to reveal associations between the ILFT scores and cognitive as well as motor impairments. Receiver operating curve (ROC) analyses were calculated to evaluate the ability of the ILFT scores to predict visuospatial impairments and dementia. RESULTS ILFT scores correlated significantly with global cognition, visuospatial functions, memory, attention, and age (p < .0125) but not with executive functions, language, education, depression, and motor impairment. The ROC analyses revealed ILFT 15 as best predictor for visuospatial deficits and dementia with an area under the curve of .82 and .88, respectively. CONCLUSION The ILFT is suitable for detecting symptoms of the posterior cortical degeneration syndrome according to the dual syndrome hypothesis. We recommend the use of the modified test version ILFT 15.
Collapse
Affiliation(s)
- Nele Schmidt
- Department of Neurology, University Oldenburg, Oldenburg, Germany
| | | | - Karsten Witt
- Department of Neurology, University Oldenburg, Oldenburg, Germany.,Research Center of Neurosensory Sciences, University Oldenburg, Oldenburg, Germany
| |
Collapse
|
4
|
Devignes Q, Daoudi S, Viard R, Lopes R, Betrouni N, Kuchcinski G, Rolland AS, Moreau C, Defebvre L, Bardinet E, Bonnet M, Brefel-Courbon C, Delmaire C, El Mountassir F, Fluchère F, Fradet A, Giordana C, Hainque E, Houvenaghel JF, Jarraya B, Klinger H, Maltête D, Marques A, Meyer M, Rascol O, Rouaud T, Tir M, Wirth T, Corvol JC, Devos D, Dujardin K. Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical Modifications. J Parkinsons Dis 2022; 12:1507-1526. [PMID: 35599498 DOI: 10.3233/jpd-223232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
BACKGROUND Parkinson's disease mild cognitive impairment (PD-MCI) is frequent and heterogenous. There is no consensus about its influence on subthalamic deep brain stimulation (STN-DBS) outcomes. OBJECTIVE To determine the prevalence of PD-MCI and its subtypes in candidates to STN-DBS. Secondarily, we sought to identify MRI structural markers associated with cognitive impairment in these subgroups. METHODS Baseline data from the French multicentric PREDISTIM cohort were used. Candidates to STN-DBS were classified according to their cognitive performance in normal cognition (PD-NC) or PD-MCI. The latter included frontostriatal (PD-FS) and posterior cortical (PD-PC) subtypes. Between-group comparisons were performed on demographical and clinical variables as well as on T1-weighted MRI sequences at the cortical and subcortical levels. RESULTS 320 patients were included: 167 (52%) PD-NC and 153 (48%) PD-MCI patients. The latter group included 123 (80%) PD-FS and 30 (20%) PD-PC patients. There was no between-group difference regarding demographic and clinical variables. PD-PC patients had significantly lower global efficiency than PD-FS patients and significantly worse performance on visuospatial functions, episodic memory, and language. Compared to PD-NC, PD-MCI patients had cortical thinning and radiomic-based changes in the left caudate nucleus and hippocampus. There were no significant differences between the PD-MCI subtypes. CONCLUSION Among the candidates to STN-DBS, a significant proportion has PD-MCI which is associated with cortical and subcortical alterations. Some PD-MCI patients have posterior cortical deficits, a subtype known to be at higher risk of dementia.
Collapse
Affiliation(s)
- Quentin Devignes
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France
| | - Sami Daoudi
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France
| | - Romain Viard
- Univ. Lille, CNRS, Inserm, US 41 - UMS 2014 - PLBS, CHU Lille, Lille Pasteur Institute, Lille, France
| | - Renaud Lopes
- Univ. Lille, CNRS, Inserm, US 41 - UMS 2014 - PLBS, CHU Lille, Lille Pasteur Institute, Lille, France
| | - Nacim Betrouni
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France
| | - Gregory Kuchcinski
- Univ. Lille, CNRS, Inserm, US 41 - UMS 2014 - PLBS, CHU Lille, Lille Pasteur Institute, Lille, France
| | - Anne-Sophie Rolland
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Department of Medical Pharmacology, NS-Park/F-CRIN, Lille, France
| | - Caroline Moreau
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France
| | - Luc Defebvre
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France
| | - Eric Bardinet
- Institut du Cerveau (ICM), Centre de Neuro-Imagerie de Recherche (CENIR), UMR S 1127, CNRS UMR 7225, Sorbonne Université, Paris, France
| | - Marie Bonnet
- Centre Expert Parkinson, NS-Park/F-CRIN, Centre Mémoire de Ressources et de Recherche, IMNc, Hôpital Pellegrin, CHU de Bordeaux, France
| | - Christine Brefel-Courbon
- Service de Neurologie B8, Centre Expert Parkinson, NS-Park/F-CRIN, Hôpital Pierre Paul Riquet, CHU Purpan, Toulouse, France
| | - Christine Delmaire
- Department of Radiology, NS-Park/F-CRIN, Hôpital Fondation A de Rothschild, Paris, France
| | - Fouzia El Mountassir
- Université Paris-Saclay, CEA, CNRS, Baobab, Neurospin, Gif-sur-Yvette, France and Institut du Cerveau (ICM), UMR S 1127, CNRS UMR 7225, Sorbonne Université, Paris, France
| | - Frédérique Fluchère
- Department of Neurology, NS-Park/F-CRIN, Assistance Publique - Hôpitaux de Marseille (APHM), Timone University Hospital and Institut de Neurosciences de la Timone, Marseille, France
| | - Anne Fradet
- Neurology Department, NS-Park/F-CRIN, University Hospital of Poitiers and INSERM, University of Poitiers, Centre d'Investigation Clinique CIC 1402, Poitiers, France
| | - Caroline Giordana
- Department of Neurology, NS-Park/F-CRIN, Centre Hospitalier Universitaire de Nice, Nice, France
| | - Elodie Hainque
- Sorbonne Université, Paris Brain Institute - ICM, NS-Park/F-CRIN, Assistance publique Hôpitaux de Paris, Inserm, CRNS, Hôpital Pitié-Salpêtrière, Department of Neurology, Paris, France
| | | | - Béchir Jarraya
- Neuroscience Pole, NS-Park/F-CRIN, Hôpital Foch, Suresnes, University of Versailles Paris-Saclay, INSERM-CEA NeuroSpin, Saclay, France
| | - Hélène Klinger
- Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, NS-Park/F-CRIN, Lyon, France
| | - David Maltête
- Department of Neurology, NS-Park/F-CRIN, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France
| | - Ana Marques
- Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, NS-Park/F-CRIN, Clermont-Ferrand, France
| | - Mylène Meyer
- Neurology department, NS-Park/F-CRIN, Central Hospital, CHRU-Nancy, Nancy, France
| | - Olivier Rascol
- Department of Clinical Pharmacology and Neuroscience, NS-Park/F-CRIN, Toulouse University Hospital, Toulouse, France
| | - Tiphaine Rouaud
- Department of Neurology, Centre Expert Parkinson, NS-Park/F-CRIN, CHU Nantes, Nantes, France
| | - Melissa Tir
- Department of Neurology, NS-PARK/FCRIN, Amiens University Hospital, Amiens, France
| | - Thomas Wirth
- Service de Neurologie, NS-Park/F-CRIN, Hôpitaux Universitaires de Strasbourg et Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France
- Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France
| | - Jean-Christophe Corvol
- Sorbonne Université, Paris Brain Institute - ICM, NS-Park/F-CRIN, Assistance publique Hôpitaux de Paris, Inserm, CRNS, Hôpital Pitié-Salpêtrière, Department of Neurology, Paris, France
| | - David Devos
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Department of Medical Pharmacology, NS-Park/F-CRIN, Lille, France
| | - Kathy Dujardin
- Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France
| |
Collapse
|
5
|
Devignes Q, Bordier C, Viard R, Defebvre L, Kuchcinski G, Leentjens AFG, Lopes R, Dujardin K. Resting-State Functional Connectivity in Frontostriatal and Posterior Cortical Subtypes in Parkinson's Disease-Mild Cognitive Impairment. Mov Disord 2021; 37:502-512. [PMID: 34918782 DOI: 10.1002/mds.28888] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Revised: 11/10/2021] [Accepted: 11/29/2021] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND The "dual syndrome hypothesis" distinguished two subtypes in mild cognitive impairment (MCI) in Parkinson's disease: frontostriatal, characterized by attentional and executive deficits; and posterior cortical, characterized by visuospatial, memory, and language deficits. OBJECTIVE The aim was to identify resting-state functional modifications associated with these subtypes. METHODS Ninety-five nondemented patients categorized as having normal cognition (n = 31), frontostriatal (n = 14), posterior cortical (n = 20), or mixed (n = 30) cognitive subtype had a 3 T resting-state functional magnetic resonance imaging scan. Twenty-four age-matched healthy controls (HCs) were also included. A group-level independent component analysis was performed to identify resting-state networks, and the selected components were subdivided into 564 cortical regions in addition to 26 basal ganglia regions. Global intra- and inter-network connectivity along with global and local efficiencies was compared between groups. The network-based statistics approach was used to identify connections significantly different between groups. RESULTS Patients with posterior cortical deficits had increased intra-network functional connectivity (FC) within the basal ganglia network compared with patients with frontostriatal deficits. Patients with frontostriatal deficits had reduced inter-network FC between several networks, including the visual, default-mode, sensorimotor, salience, dorsal attentional, basal ganglia, and frontoparietal networks, compared with HCs, patients with normal cognition, and patients with a posterior cortical subtype. Similar results were also found between patients with a mixed subtype and HCs. CONCLUSION MCI subtypes are associated with specific changes in resting-state FC. Longitudinal studies are needed to determine the predictive potential of these markers regarding the risk of developing dementia. © 2021 International Parkinson and Movement Disorder Society.
Collapse
Affiliation(s)
- Quentin Devignes
- Univ. Lille, Inserm 1172, Lille Neurosciences and Cognition, CHU Lille, Lille, France
| | - Cécile Bordier
- Univ. Lille, Inserm 1172, Lille Neurosciences and Cognition, CHU Lille, Lille, France.,Univ. Lille, CNRS, Inserm, US 41-UMS 2014-PLBS, CHU Lille, Lille Pasteur Institute, Lille, France.,Department of Neuroradiology, CHU Lille, Lille, France
| | - Romain Viard
- Univ. Lille, Inserm 1172, Lille Neurosciences and Cognition, CHU Lille, Lille, France.,Univ. Lille, CNRS, Inserm, US 41-UMS 2014-PLBS, CHU Lille, Lille Pasteur Institute, Lille, France.,Department of Neuroradiology, CHU Lille, Lille, France
| | - Luc Defebvre
- Univ. Lille, Inserm 1172, Lille Neurosciences and Cognition, CHU Lille, Lille, France.,Neurology and Movement Disorders Department, CHU Lille, Lille, France
| | - Grégory Kuchcinski
- Univ. Lille, Inserm 1172, Lille Neurosciences and Cognition, CHU Lille, Lille, France.,Univ. Lille, CNRS, Inserm, US 41-UMS 2014-PLBS, CHU Lille, Lille Pasteur Institute, Lille, France.,Department of Neuroradiology, CHU Lille, Lille, France
| | - Albert F G Leentjens
- Department of Psychiatry, Maastricht University Medical Centre, Maastricht, The Netherlands
| | - Renaud Lopes
- Univ. Lille, Inserm 1172, Lille Neurosciences and Cognition, CHU Lille, Lille, France.,Univ. Lille, CNRS, Inserm, US 41-UMS 2014-PLBS, CHU Lille, Lille Pasteur Institute, Lille, France.,Department of Neuroradiology, CHU Lille, Lille, France
| | - Kathy Dujardin
- Univ. Lille, Inserm 1172, Lille Neurosciences and Cognition, CHU Lille, Lille, France.,Neurology and Movement Disorders Department, CHU Lille, Lille, France
| |
Collapse
|